Category Archives: Corporate Responsibility

Antibiotics Discovery: Time for a ‘Manhattan Project’

by Susan Crowley The innovative pharmaceutical industry is under attack from critics around the world for failing to develop new antibiotics to treat emerging infections. The charge has been furthered by statements from World Health Organization (WHO) director Margaret Chan. In 2012, she warned that bacteria were starting to become so resistant to common antibiotics […]
Also posted in Global, Guest Blog, healthcare, IP, leadership, Manufacturing, Market Access, R&D, Strategy | Tagged , , , , , , , | 4 Comments

The United Kingdom: Rx for America's Pharma Tax Blues?

by Tom Norton The dizzying flurry of press releases from both Pfizer Inc. and AstraZeneca over a possible PFE acquisition of AZN have Rx experts on both sides of the Atlantic buzzing… From the US side, the most frequent thing that I have heard over the last 48 hours is, “You have got to be […]
Also posted in Deals, Europe, FDA, Global, Guest Blog, leadership, Legal, People, Strategy | Tagged , , , , , , , , | 1 Comment

The US Biotech Drug Pricing Challenge

by Tom Norton In the midst of the hue and cry last week over the public release of individual Medicare payments to physicians, I was surprised to read that one of Medicare’s most costly medical services is — ophthalmology.  According to the New York Times: “One of the most heavily reimbursed procedures — costing a […]
Also posted in Biotech, Guest Blog, healthcare, Market Access, pricing, Strategy | Tagged , , , , , , , , | 1 Comment

Stop Paying Lip Service to Patient-Centricity

by Michael Edwards Pharma has operated the same way for 100 years, but the US healthcare model has changed completely in the last 30 years, for payers, pharmacists, hospitals, and even at the clinician level. These changes necessitate pharma – a traditionally stagnant partner – to change now or further risk having its stubbornness result […]
Also posted in Guest Blog, leadership, Patient Communication, patient compliance, patient education, People, Strategy | Tagged , , , | Leave a comment

After Delays, Project DataSphere Rolls Out

An industry and academic data-sharing project went live on Tuesday, nearly a year after the platform was expected to launch. Visitors to the site – no credentials needed – can register and access de-identified clinical data from the comparator arms of nine oncology trials, with more to come. Project DataSphere, the newest data transparency and […]
Also posted in Biotech, Europe, FDA, Global, IP, leadership, Legal, R&D, Strategy, Technology | Tagged , , , , , , , , , | Leave a comment
  • Categories

  • Meta